Several prescription drug manufacturers have either enacted or enhanced programs that provide discounted prescription drugs to people in financial need during the COVID pandemic. You may be eligible to receive discounted or free prescription refills if you have suffered financial loss during the COVID pandemic.
- Prescription insulin can be expensive even with insurance. Several insulin manufactures have discount programs including the following:
- Novo Nordisk (Novolin and other types of insulin): https://www.novonordisk-us.com/media/news-releases.html?122988
- Eli Lilly (Humolog and other types of insulin) has capped their co-pay at $35: https://www.lilly.com/news/stories/covid19-crisis-lilly-introduces-35-dollar-copay-insulin
- Sanofi (Lantus and other types of insulin) has a patient assistance program expanded during this time: http://www.news.sanofi.us/2019-04-10-Sanofi-provides-unprecedented-access-to-its-insulins-for-one-set-monthly-price
- Insulet (OmniPod delivery system) financial assistance program: https://investor.insulet.com/news-releases/news-release-details/insulet-expands-its-us-financial-assistance-program-current
- Even with Medicare Part D, prescription drug prices can be out of reach for many people. Medicare has a database of prescription drug discount programs here: https://www.medicare.gov/pharmaceutical-assistance-program/
- There are many other prescription drug assistance programs run by various drug manufacturers. Your drug’s manufacturer website will have information about whether it has a prescription assistance program that applies to you.